Literature DB >> 23333820

Type II diabetes promotes a myofibroblast phenotype in cardiac fibroblasts.

Vennece Fowlkes1, Jessica Clark, Charity Fix, Brittany A Law, Mary O Morales, Xian Qiao, Kayla Ako-Asare, Jack G Goldsmith, Wayne Carver, David B Murray, Edie C Goldsmith.   

Abstract

AIMS: Cardiovascular disease is the leading cause of death for individuals diagnosed with type II diabetes mellitus (DM). Changes in cardiac function, left ventricular wall thickness and fibrosis have all been described in patients and animal models of diabetes; however, the factors mediating increased matrix deposition remain unclear. The goal of this study was to evaluate whether cardiac fibroblast function is altered in a rat model of type II DM. MAIN
METHODS: Cardiac fibroblasts were isolated from 14 week old Zucker diabetic and lean control (LC) adult male rat hearts. Fibroblasts were examined for their ability to remodel 3-dimensional collagen matrices, their adhesion, migration and proliferation on collagen and changes in gene expression associated with collagen remodeling. KEY
FINDINGS: Cardiac fibroblasts from diabetic animals demonstrated significantly greater ability to contract 3-dimensional collagen matrices compared to cardiac fibroblasts from LC animals. The enhanced contractile behavior was associated with an increase in diabetic fibroblast proliferation and elevated expression of α-smooth muscle actin and type I collagen, suggesting the transformation of diabetic fibroblasts into a myofibroblast phenotype. SIGNIFICANCE: Cardiac fibrosis is a common complication in diabetic cardiomyopathy which may contribute to the observed cardiac dysfunction associated with this disease. Identifying and understanding the changes in fibroblast behavior which contribute to the increased deposition of collagen and other matrix proteins may provide novel therapeutic targets for reducing the devastating effects of diabetes on the heart.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23333820      PMCID: PMC3810176          DOI: 10.1016/j.lfs.2013.01.003

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  32 in total

Review 1.  Structural and functional characterisation of cardiac fibroblasts.

Authors:  Patrizia Camelliti; Thomas K Borg; Peter Kohl
Journal:  Cardiovasc Res       Date:  2005-01-01       Impact factor: 10.787

2.  In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro.

Authors:  Chun-Chi Liang; Ann Y Park; Jun-Lin Guan
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  Adaptive changes in cardiac fibroblast morphology and collagen organization as a result of mechanical environment.

Authors:  Sarah C Baxter; Mary O Morales; Edie C Goldsmith
Journal:  Cell Biochem Biophys       Date:  2008-04-30       Impact factor: 2.194

4.  Effects of elevated glucose levels on interactions of cardiac fibroblasts with the extracellular matrix.

Authors:  Xiaoyi Zhang; James A Stewart; Ian D Kane; Erin P Massey; Dawn O Cashatt; Wayne E Carver
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-09-12       Impact factor: 2.416

5.  Impaired proliferation and increased L-lactate production of dermal fibroblasts in the GK-rat, a spontaneous model of non-insulin dependent diabetes mellitus.

Authors:  K Hehenberger; A Hansson; J D Heilborn; S M Abdel-Halim; C G Ostensson; K Brismar
Journal:  Wound Repair Regen       Date:  1999 Jan-Feb       Impact factor: 3.617

Review 6.  The cardiac fibroblast: therapeutic target in myocardial remodeling and failure.

Authors:  R Dale Brown; S Kelly Ambler; M Darren Mitchell; Carlin S Long
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

7.  Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase.

Authors:  James S Swaney; David M Roth; Erik R Olson; Jennifer E Naugle; J Gary Meszaros; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-29       Impact factor: 11.205

8.  Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production.

Authors:  Vivek P Singh; Kenneth M Baker; Rajesh Kumar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-02-22       Impact factor: 4.733

9.  Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E.

Authors:  Juan Asbun; Ana Maria Manso; Francisco J Villarreal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-09-02       Impact factor: 4.733

10.  Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse.

Authors:  Indroneal Banerjee; John W Fuseler; Robert L Price; Thomas K Borg; Troy A Baudino
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-29       Impact factor: 4.733

View more
  30 in total

1.  The ubiquitin ligase WWP1 contributes to shifts in matrix proteolytic profiles and a myocardial aging phenotype with diastolic heart.

Authors:  Lydia E Matesic; Lisa A Freeburg; Laura B Snyder; Lauren-Ashley Duncan; Amber Moore; Paige E Perreault; Kia N Zellars; Edie C Goldsmith; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-08-21       Impact factor: 4.733

Review 2.  The present and future role of ultrasound targeted microbubble destruction in preclinical studies of cardiac gene therapy.

Authors:  Lijun Qian; Barsha Thapa; Jian Hong; Yanmei Zhang; Menglin Zhu; Ming Chu; Jing Yao; Di Xu
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

Review 3.  Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart.

Authors:  Jia Zhao; Rushil Randive; James A Stewart
Journal:  World J Diabetes       Date:  2014-12-15

Review 4.  Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.

Authors:  Ilaria Russo; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2015-12-15       Impact factor: 5.000

Review 5.  Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities.

Authors:  Michele Cavalera; Junhong Wang; Nikolaos G Frangogiannis
Journal:  Transl Res       Date:  2014-05-10       Impact factor: 7.012

Review 6.  Non-ischemic dilated cardiomyopathy and cardiac fibrosis.

Authors:  Bianca Olivia Cojan-Minzat; Alexandru Zlibut; Lucia Agoston-Coldea
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

7.  Identifying Phenotypically Distinct Fibroblast Subsets in Type 2 Diabetes-Associated Iatrogenic Laryngotracheal Stenosis.

Authors:  Ioan A Lina; Alexandra Berges; Rafael Ospino; Ruth J Davis; Kevin M Motz; Hsiu-Wen Tsai; Samuel Collins; Alexander T Hillel
Journal:  Otolaryngol Head Neck Surg       Date:  2021-06-15       Impact factor: 3.497

8.  Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition.

Authors:  Alexander R Pinto; Rebecca H Ritchie; Charles D Cohen; Miles J De Blasio; Man K S Lee; Gabriella E Farrugia; Darnel Prakoso; Crisdion Krstevski; Minh Deo; Daniel G Donner; Helen Kiriazis; Michelle C Flynn; Taylah L Gaynor; Andrew J Murphy; Grant R Drummond
Journal:  Cardiovasc Diabetol       Date:  2021-06-01       Impact factor: 9.951

9.  Rap1a Regulates Cardiac Fibroblast Contraction of 3D Diabetic Collagen Matrices by Increased Activation of the AGE/RAGE Cascade.

Authors:  Stephanie D Burr; James A Stewart
Journal:  Cells       Date:  2021-05-22       Impact factor: 6.600

Review 10.  Electrical Features of the Diabetic Myocardium. Arrhythmic and Cardiovascular Safety Considerations in Diabetes.

Authors:  Mónica Gallego; Julián Zayas-Arrabal; Amaia Alquiza; Beatriz Apellaniz; Oscar Casis
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.